Don Wang

Don Wang has extensive work experience in the pharmaceutical industry, spanning over two decades. Don'smost recent role is as the Vice President of Product Development (CMC) at Palatin Technologies, where they are responsible for the development and manufacturing of API and Drug Products. Don oversees the supply chain for both commercial and clinical pipeline products.

Prior to their current position, Don worked as the Vice President of the Research Institute at Huahai Pharmaceutical Co., Ltd. During their tenure, they held leadership roles in various organizations, including Director of Research & Development at American Regent, Inc., Director of Product Development at Virtus Pharmaceuticals, and VP of Prod Dev at TOLMAR Inc.

Don has demonstrated their expertise in leading R&D organizations, formulating generic drugs, and managing research projects. Don has experience in various drug delivery technologies and has successfully launched products in the market. Additionally, they have worked on API and Drug Product development for new drug entities, both internally and through partnerships.

Don's career includes working in companies such as Endo Pharmaceuticals, Merial (a Sanofi Company), Pivot PharmaTech, Shanghai, Actavis, and KV Pharmaceutical. Throughout their career, they have focused on formulating a wide range of drug products, including creams, ointments, gels, liquids, suppositories, and pessaries.

Overall, Don Wang has a wealth of experience in pharmaceutical research and development, formulation, and project management. Don has a proven track record of successfully leading teams and delivering results in the industry.

Don Wang earned their Master of Science degree in Chemistry from California State University, Northridge from 1983 to 1985. Subsequently, they pursued a Ph.D. in Chemistry (Inorganic) at Northwestern University from 1985 to 1989.